IgG4-related disease: A proteiform pathology with frequent chest manifestations - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Revue des Maladies Respiratoires Année : 2023

IgG4-related disease: A proteiform pathology with frequent chest manifestations

Maladie associée aux IgG4 : une maladie protéiforme aux manifestations thoraciques fréquentes

Résumé

Introduction: While IgG4-related disease (IgG4-RD) was initially described in the early 2000s, its polymorphic clinical manifestations were previously reported under different names ; they have in common the presence of IgG4+ oligoclonal plasma cells and fibrosis. State of the art: Ruling out certain differential diagnoses, the diagnosis of IgG4-RD is based on a bundle of clinical, biological and histological features. Chest involvement is variable and can affect the mediastinum, bronchi, parenchyma, pleura and/or, more rarely, bones and (pericardium, aorta, coronary…) vascular structures. The most frequent radiological manifestations are peribronchovascular thickening, mediastinal lymphadenopathy, and nodular or interstitial patterns. Pleural involvement and posterior mediastinal fibrosis are less frequent, while thoracic paravertebral tissue thickening is highly specific. Systemic corticosteroids are the cornerstone of treatment. In case of relapse or as frontline therapy in case of risk factors for relapse and/or poor tolerance of corticosteroids), a steroid-sparing agent (most often rituximab) is added, and biannual maintenance infusions are associated with a lower risk of relapse. Perspectives: An international consensus has recently led to the development of classification criteria that should standardize the diagnostic approach and homogenize the enrolment of patients in epidemiological as well as therapeutic studies. Other treatments are also under evaluation, including biologics targeting T2 inflammation, CD-19 (inebilizumab, obexelimab), SLAMF7 (elotuzumab) surface proteins, Bruton's tyrosine kinase, and the JAK/STAT pathway. Conclusions: Substantial progress has been made over recent years in understanding IgG4-RD pathophysiology, and personalized patient care seems to be an achievable medium-term goal.
Fichier non déposé

Dates et versions

hal-04452755 , version 1 (12-02-2024)

Identifiants

Citer

M. Groh, P. Habert, M. Ebbo, R. Muller, L. Gaigne, et al.. IgG4-related disease: A proteiform pathology with frequent chest manifestations. Revue des Maladies Respiratoires, 2023, 40 (9-10), pp.768-782. ⟨10.1016/j.rmr.2023.10.001⟩. ⟨hal-04452755⟩

Collections

UNIV-AMU
7 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More